Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.64643 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.33438 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 5.67063 | 80 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.04205 | 82 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.69344 | 80 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.65192 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.41073 | 79 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.83819 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.84893 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.60433 | 79 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.28334 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.49447 | 79 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.66006 | 80 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.45238 | 79 |